| Catalog | name | Description | price |
|---|---|---|---|
| R-C-3091 | TAK-593 CAS:1005780-62-0 | TAK-593 is an oral formulation containing a small-molecule receptor tyrosine kinase inhibitor of both vascular endothelial growth factor receptor (VEGFR) and platelet-derived growth factor receptor (PDGFR) with potential antineoplastic activity.Only for scientific research, not for human body. | price> |
| R-C-3092 | SU5402 CAS:215543-92-3 | SU5402 is a potent multi-targeted receptor tyrosine kinase inhibitor with IC50 of 20 nM, 30 nM, and 510 nM for VEGFR2, FGFR1, and PDGF-Rβ, respectively.Only for scientific research, not for human body. | price> |
| R-C-3093 | SAR131675 CAS:1433953-83-3 | SAR131675, a potent and selective VEGFR-3-TK inhibitor with antilymphangiogenic, antitumoral, and antimetastatic activities.Only for scientific research, not for human body. | price> |
| R-C-3094 | SU 5416 (Semaxinib) CAS: 204005-46-9 | SU 5416 is an inhibitor of vascular endothelial growth factor receptor (VEGFR) that also inhibits other tyrosine kinases KIT, MET, FLT3 and RET.Only for scientific research, not for human body. | price> |
| R-C-3095 | CP-547632 CAS:252003-65-9 | CP-547632 is a novel, potent vascular endothelial growth factor receptor-2 tyrosine kinase inhibitor.Only for scientific research, not for human body. | price> |
| R-C-3096 | CP-673451 CAS:343787-29-1 | CP-673451 is a selective inhibitor of PDGFRα/β with IC50 of 10 nM/1 nM in cell-free assays, exhibits >450-fold selectivity over other angiogenic receptors, has antiangiogenic and antitumor activity.Only for scientific research, not for human body. | price> |

Items-$0.00

Email:
Tel.:
RuixiBiotechCo.Ltd /KamulinBiotechco.ltd
Add: Room 20F 2002, Meiyuan Building, Yanta District, Xi’ an City, Shaanxi Province 710061 China
Tel: 02988811435
Fax: (86-29)8881-1435
Email: sales@ruixibiotech.com
Web: http://www.ruixibiotech.com


